Ditemukan 1 dokumen yang sesuai dengan query
Zulkifli Amin
"
ABSTRACT
Lung cancer is a devastating disease with a high incidence, mortality and morbidity rate, especially in developing countries. Conventional treatment with cytotoxic chemotherapy has some limitations attributed to chemoresistance and toxicity. Recent advances have shown that first generation Tyrosine Kinase Inhibitor (TKI), Gefitinib and Erlotinib, and the newest available second generation Tyrosine Kinase Inhibitor (TKI), Afatinib, have the potential to be an option in the management of patients with epidermal growth factor receptor/ EGFR mutation ...
"
Jakarta: University of Indonesia. Faculty of Medicine, 2017
610 UI-IJIM 49: 1 (2017)
Artikel Jurnal Universitas Indonesia Library